A newsletter for those involved in clinical trials. Published 20 times a year by Canary Ltd

GCP compliance and implementation

The following articles on this topic have been published in CRAdvisor (CRA) – the year, issue number and starting page number for each are listed below:

Back to index

2007  
CRA 2007; 187:4 BARQA to pilot a GCP inspection database.
CRA 2007; 192:6 Coordination of pre-approval GxP inspections.
CRA 2007: 192:7 CDER issues new warnings to investigators.
CRA 2007: 195:3 New MHRA guidance on responding to inspection findings.
   
2006  
CRA 2006; 169:1 Grey areas at GCP/GMP interface.
CRA 2006; 174:1 Russian GCP now in force.
CRA 2006; 175:3 Draft GCP guidelines published for Pan American region.
CRA 2006; 176:11 UK's GCP Consultative Committee meeting addresses concerns.
CRA 2006; 178:4 GCP principles: comparison between UK regulations and ICH GCP guidelines.
CRA 2006; 179:7 Whistleblowing triggers for-cause inspections.
CRA 2006; 180:3 Protocol waivers in common use: is this wise?
   
2005  
CRA 2005; 144:4 European Directives affecting clinical trials in 2005: an overview.
CRA 2005; 145:1 European Commission issues Q&A document on implementing GCP requirements in Europe.
CRA 2005; 149:1 European Commission Directive on GCP 2005/28/EC now published.
   
2004  
CRA 2004; 123:7 Further guidance to support Directive 2001/20/EC implementation.
CRA 2004; 123:7 UK Department of Health enters into joint project with MRC to meet needs of Directive 2001/20/EC.
CRA 2004; 129:5 Making your sites suitable for trials: documents and filing.
CRA 2004; 133:6 FDA to revise regulations on foreign studies.
CRA 2004; 135:1 Long-awaited Commission Directive on GCP released for consultation.
CRA 2004; 141:6 India announces legislation to make GCP compliance mandatory.
   
2003  
CRA 2003; 103:1 Scope of WHO GCP Guidelines widened in new revision.
CRA 2003; 105:4 GCP guidelines: a new Directive.
CRA 2003; 107:1 UK releases proposals for new clinical trial regulations.
CRA 2003; 108:2 Industry warns European Parliament of major concerns with GCP Directive.
   
2002  
CRA 2002; 82:5 The impact and consequences of protocol violations.
CRA 2002; 89:4 Version control vital to ensure GCP compliance.
CRA 2002; 92:5 Procedures for the verification of GCP compliance.
CRA 2002; 93:8 MCA not to inspect Ethics Committees.
CRA 2002; 94:1 New guidance on the principles of GCP in the conduct in the European clinical trials.
CRA 2002; 97:5 Adhere to ICH GCP and make it plain!  
CRA 2002; 100:4 Current status of key European clinical research guidelines.
   
2001  
CRA 2001; 67:4 Solutions to common GCP problems?
CRA 2001; 75:4 Sponsor or not a sponsor?
CRA 2001; 76:3 WHO guidelines on good clinical practice reviewed.
CRA 2001; 77:4 Archiving on CD-ROM.
   
2000  
CRA 2000; 43:5 GCP question on code breaking. 
CRA 2000; 48:1 Poor GCP compliance by investigator is still major source of concern. 
CRA 2000; 49:6 Research law in Finland. 
CRA 2000; 53:6 GCP in Australia. 
   
1999  
CRA 1999; 20:2 New clinical research legislation in the Slovak Republic. 
CRA 1999; 25:4 GCP implementation problems. 
CRA 1999; 26:4 GCP implementation problems. 
CRA 1999; 28:3 GCP implementation problems. 
CRA 1999; 29:2 GCP and the use of electronic communications. 
CRA 1999; 30:2 Compliance with GCP. 
CRA 1999; 32:6 ICH GCP complicates trials in Japan. 
CRA 1999; 35:2 Is full GCP necessary in Phase IV? 
CRA 1999; 36:5 Trials to be conducted to ICH GCP in Poland. 
   
1998  
CRA 1998; 3:1 Retrospective GCP compliance dangerous. 
CRA 1998; 4:5 GCP compliance begins in Japan. 
CRA 1998; 5:3 GCP compliance problems in the Netherlands. 
CRA 1998; 6:1 ICH GCP becomes a legal requirement in the Netherlands. 
CRA 1998; 7:5 GCP in Argentina. 
CRA 1998; 8:1 Adoption of EU GCP Directive hindered by delays. 
CRA 1998; 8:2 Academic units may have problems with EU GCP Directive. 
CRA 1998; 8:6 MRC introduces more guidelines on GCP. 
CRA 1998; 12:1 Poor levels of GCP compliance by investigators. 
CRA 1998; 13:6 ICH GCP now law in Italy. 
CRA 1998; 15:4 Multinational, multicentre studies: the pros and cons. 
CRA 1998; 18:3 GCP deficiencies in CEE and Western Europe. 
CRA 1998; 18:4 Detecting consent problems in the Slovak Republic. 
   
1997  
CRA 1997; 1:1 Draft EU Directive on GCP now with European Parliament.

Top